Expo West 2026: Building Brands That Shoppers Come Back To
At Natural Products Expo West this year, we double clicked into a real challenge for emerging brands: discovery creates momentum, but repeat purchase determines growth.
Why Pharmaceutical Returns Policies Are Becoming More Complex
Pharmaceutical returns have never been simple, but the rules that govern them are becoming more complicated each year. What once relied on a relatively small set of manufacturer guidelines has expanded into a patchwork of policies that vary by product, timing and eligibility.Inmar Intelligence and Eagle Eye Partner to Simplify Digital Offer Activation for Retailers
Inmar Intelligence, a leader in data-driven media and incentive technology, today announced a multi-year integration with Eagle Eye, a leading SaaS and AI marketing technology company. The partnership connects Inmar’s robust digital offer content with Eagle Eye’s MACH certified retail promotions platform, enabling retailers across North America to activate Inmar digital coupons directly within their existing wallet, promotions, and point-of-sale environments.
POSSIBLE 2026
POSSIBLE brings together the leaders shaping the future of marketing, media, and commerce. It’s a place for brands, retailers, and technology partners to share ideas, explore new approaches, and find simplicity in an increasingly complex media landscape.
What Dealers are Prioritizing Now: Key Takeaways from NADA Show 2026
We came to NADA Show 2026 to listen as much as we presented. Over three days, we hosted a series of live platform demonstrations and spent time digging into how Fixed Ops teams are actually operating today.
Three’s Company, Four’s Excluded: Structural Gaps in the FTC–Express Scripts Settlement
By Lari Harding, SVP, Industry Affairs & Strategic Partnerships, Inmar Intelligence The Federal Trade Commission (FTC) has proposed a consent order with Express Scripts (ESI), one of the nation’s largest pharmacy benefit managers (PBMs), to resolve allegations related to insulin pricing practices and broader competition concerns.
What the Latest Data Shows About Unsaleable Returns
Pharmaceutical returns are often treated as a routine task. Products expire, recalls happen and inventory is cleared out as needed. But recent data shows that unsaleable returns are more than an operational chore. They offer insight into financial performance, compliance risk and how well pharmacy operations are keeping up with a changing supply chain.
2026 NoLo Alcohol Report
Our 2026 NoLo Trends Report explores 3 trends influencing category growth and what they mean for planning in the year ahead.